Real World Evidence of Benralizumab in Eosinophilic Severe AsThma in Russia (BEST)

Clinical trial NCT05271526 · COMPLETED

Trial details

NCT number: NCT05271526
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Severe Eosinophilic Asthma

Start date: 2022-05-16
Primary completion: 2023-11-13
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.